SpecialtiesQuestion

What is your preferred adjuvant systemic treatment for a patient with isolated melanoma brain metastasis following complete resection and SRS to the tumor bed?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

How, if at all, are you modifying your practice and clinical workflow for patients receiving checkpoint inhibitors with data showing improved outcomes for patients receiving infusions earlier in the day?

In elderly patients with advanced melanoma and idiopathic pulmonary fibrosis receiving active antifibrotic therapy, would neoadjuvant or adjuvant immune checkpoint inhibition be preferred?

How do you approach biopsy and management decisions for a rapidly enlarging periocular tumor in an elderly patient with dementia who is unable to communicate and whose family prefers to avoid aggressive treatment?

How do gene expression profiling results impact your decisions regarding adjuvant therapy in node-negative or borderline-risk melanoma patients?

What are the main limitations or barriers to integrating gene expression profiling into routine melanoma management in your practice?

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
Mobile App

Company

About
Careers
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.